| Authors: |
Jordan K; Department of Hematology, Oncology and Palliative Care, Ernst von Bergmann Hospital Potsdam, Germany; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany. Electronic address: Karin.Jordan@med.uni-heidelberg.de., de Azambuja E; Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B) and l'Université Libre de Bruxelles (ULB), Brussels, Belgium., García Del Barrio MÁ; Pharmacy Department, Clínica Universidad de Navarra, Universidad de Navarra, Madrid, Spain; School of Pharmacy and Nutrition, Universidad de Navarra, Pamplona, Spain., Jahn F; Department of Hematology and Oncology, University Hospital Martin-Luther University Halle-Wittenberg, Halle, Germany., Di Palma M; Interdisciplinary Patient Pathway Division, Gustave Roussy, Villejuif, France., Scotté F; College of Arts, Humanities and Education, University of Derby, Derby, UK., Molassiotis A; Medical Oncology, Genolier Cancer Center, Genolier, Switzerland., Aapro M; Medical Oncology, Genolier Cancer Center, Genolier, Switzerland. |
